MINERVAX ApS: Financial statements 2024
CVR: 32673287
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2024. In 2024, the company reported a net result of EUR -29,126,000 compared with EUR -27,077,000 the year before. Equity in the 2024 report amounted to EUR 39,808,000. The solvency ratio was 53.2%. The company had 53 employees in the financial year.
- Profit/Loss
- EUR -29,126,000
- Equity
- EUR 39,808,000
- Total Assets
- EUR 74,813,000
- Employees
- 53
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | -29.1 mio. EUR | 39.8 mio. EUR | 53 |
| 2023 | - | - | -27.1 mio. EUR | 67.6 mio. EUR | - |
| 2022 | - | -98.2 mio. | -108 mio. | 304.7 mio. | 7 |
| 2021 | - | -57.8 mio. | -61.9 mio. | 98.7 mio. | 7 |
| 2020 | - | -16.8 mio. | -19.5 mio. | 156 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of November 13, 2024, Veronica Gambillara Fonck has joined the board of directors of MINERVAX ApS.
As of November 13, 2024, Dr. Gerd Werner Zettlmeissl has left the board of directors of MINERVAX ApS.
As of November 12, 2024, Veronica Gambillara Fonck has left the board of directors of MINERVAX ApS.
MINERVAX ApS has published its annual report for 2023. The net result was DKK -27,077,000.
As of May 17, 2024, Patrik Sobocki has joined the board of directors of MINERVAX ApS.
As of May 17, 2024, Regina Hodits has joined the board of directors of MINERVAX ApS.
As of May 17, 2024, Jonas Karl Olof Brambeck has left the board of directors of MINERVAX ApS.
As of May 17, 2024, Karl Nägler has left the board of directors of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 28 employees (2026). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.